(BEI) Beiersdorf - XETRA

Sector: Consumer Defensive | Industry: Household & Personal Products | Exchange: XETRA (Germany) | Market Cap: 15.358m EUR | Total Return: -35.3% in 12m

Skin Care, Body Care, Adhesive Tapes, Medical Plasters
Total Rating 36
Safety 68
Buy Signal -0.83
Household & Personal Products
Industry Rotation: +10.3
Market Cap: 17.8B
Avg Turnover: 27.2M
Risk 3d forecast
Volatility28.5%
VaR 5th Pctl4.86%
VaR vs Median3.56%
Reward TTM
Sharpe Ratio-1.40
Rel. Str. IBD8.3
Rel. Str. Peer Group26.2
Character TTM
Beta0.093
Beta Downside0.237
Hurst Exponent0.584
Drawdowns 3y
Max DD53.28%
CAGR/Max DD-0.29
CAGR/Mean DD-0.87
EPS (Earnings per Share) EPS (Earnings per Share) of BEI over the last years for every Quarter: "2021-06": 1.53, "2021-09": 1.21, "2021-12": 1.21, "2022-03": 0, "2022-06": 1.98, "2022-09": 1.15, "2022-12": 1.15, "2023-03": 0, "2023-06": 1.93, "2023-09": 1.32, "2023-12": 1.4, "2024-03": 0, "2024-06": 2.77, "2024-09": 0, "2024-12": 1.48, "2025-03": 1.48, "2025-06": 2.47, "2025-12": 1.771,
EPS CAGR: 14.46%
EPS Trend: 71.9%
Last SUE: -2.72
Qual. Beats: -4
Revenue Revenue of BEI over the last years for every Quarter: 2021-06: 3874, 2021-09: 1906.75, 2021-12: 3753, 2022-03: 2199.75, 2022-06: 4476, 2022-09: 2199.75, 2022-12: 4323, 2023-03: 2199.75, 2023-06: 4936, 2023-09: null, 2023-12: 4511, 2024-03: null, 2024-06: 5175, 2024-09: null, 2024-12: 4675, 2025-03: null, 2025-06: 2594, 2025-12: 4664,
Rev. CAGR: 2.12%
Rev. Trend: 86.8%
Last SUE: 0.00
Qual. Beats: 0

Warnings

No concerns identified

Tailwinds

No distinct edge detected

Description: BEI Beiersdorf

Beiersdorf Aktiengesellschaft is a Hamburg-based multinational corporation specializing in personal care products and industrial adhesive technologies. The company operates through two primary segments: Consumer Business, which manages a portfolio of global skin and body care brands such as NIVEA, Eucerin, and La Prairie, and the Tesa Business, which develops self-adhesive solutions for the automotive and electronics industries.

The business model relies on a dual-track strategy of mass-market dominance and high-margin selective cosmetics. This structure allows the company to leverage stable consumer demand for hygiene products while capturing growth in specialized industrial applications. The personal care sector is characterized by high brand loyalty and significant research and development requirements to maintain competitive advantages in dermatological efficacy.

Investors can evaluate the underlying fundamentals and valuation metrics of this German blue-chip stock on ValueRay. Founded in 1882, Beiersdorf maintains an extensive international distribution network across Europe, the Americas, Asia, and Africa, operating as a majority-owned subsidiary of maxingvest ag.

Headlines to Watch Out For
  • NIVEA market share growth in emerging economies drives core consumer revenue
  • Demand for premium brands La Prairie and Chantecaille impacts overall profit margins
  • Tesa segment performance fluctuates with global automotive and electronics manufacturing cycles
  • Rising raw material and logistics costs pressure consumer business operating margins
  • Strategic expansion in North American skin care market accelerates top-line growth
Piotroski VR-10 (Strict) 6.0
Net Income: 663.0m TTM > 0 and > 6% of Revenue
FCF/TA: 0.03 > 0.02 and ΔFCF/TA -3.32 > 1.0
NWC/Revenue: 43.43% < 20% (prev 27.87%; Δ 15.56% < -1%)
CFO/TA 0.06 > 3% & CFO 821.0m > Net Income 663.0m
Net Debt (-906.0m) to EBITDA (1.14b): -0.79 < 3
Current Ratio: 1.90 > 1.5 & < 3
Outstanding Shares: last quarter (218.5m) vs 12m ago -3.66% < -2%
Gross Margin: 57.12% > 18% (prev 58.48%; Δ -1.35% > 0.5%)
Asset Turnover: 56.14% > 50% (prev 75.71%; Δ -19.57% > 0%)
Interest Coverage Ratio: 36.98 > 6 (EBIT TTM 887.5m / Interest Expense TTM 24.0m)
Altman Z'' 6.71
A: 0.25 (Total Current Assets 6.66b - Total Current Liabilities 3.51b) / Total Assets 12.8b
B: 0.77 (Retained Earnings 9.88b / Total Assets 12.8b)
C: 0.07 (EBIT TTM 887.5m / Avg Total Assets 12.9b)
D: 2.03 (Book Value of Equity 8.60b / Total Liabilities 4.23b)
Altman-Z'' = 6.71 = AAA
Beneish M -2.71
DSRI: 1.68 (Receivables 2.21b/1.79b, Revenue 7.26b/9.85b)
GMI: 1.02 (GM 58.48% / 57.12%)
AQI: 0.88 (AQ_t 0.26 / AQ_t-1 0.30)
SGI: 0.74 (Revenue 7.26b / 9.85b)
TATA: -0.01 (NI 663.0m - CFO 821.0m) / TA 12.8b)
Beneish M = -2.71 (Cap -4..+1) = A
What is the price of BEI shares?

As of June 15, 2026, the stock is trading at EUR 70.54 with a total of 366,307 shares traded.
Over the past week, the price has changed by +0.77%, over one month by -0.06%, over three months by -6.41% and over the past year by -35.32%.

Is BEI a buy, sell or hold?

Beiersdorf has no consensus analysts rating.

Beiersdorf (BEI) - Fundamental Data Overview as of 13 June 2026
Market Cap USD = 17.8b (15.4b EUR * 1.1565 EUR.USD)
P/E Trailing = 16.5365
P/E Forward = 19.7239
P/S = 1.5589
P/B = 1.7973
P/EG = 2.6423
Revenue TTM = 7.26b EUR
EBIT TTM = 887.5m EUR
EBITDA TTM = 1.14b EUR
Long Term Debt = 117.0m EUR (from longTermDebt, last quarter)
Short Term Debt = 100.0m EUR (from shortTermDebt, last quarter)
Debt = 294.0m EUR (from shortLongTermDebtTotal, last quarter) + Leases 77.0m
Net Debt = -906.0m EUR (calculated: Debt 294.0m - CCE 1.20b)
Enterprise Value = 14.5b EUR (15.4b + Debt 294.0m - CCE 1.20b)
Interest Coverage Ratio = 36.98 (Ebit TTM 887.5m / Interest Expense TTM 24.0m)
EV/FCF = 37.10x (Enterprise Value 14.5b / FCF TTM 389.5m)
FCF Yield = 2.70% (FCF TTM 389.5m / Enterprise Value 14.5b)
FCF Margin = 5.37% (FCF TTM 389.5m / Revenue TTM 7.26b)
Net Margin = 9.13% (Net Income TTM 663.0m / Revenue TTM 7.26b)
Gross Margin = 57.12% ((Revenue TTM 7.26b - Cost of Revenue TTM 3.11b) / Revenue TTM)
Gross Margin QoQ = 55.87% (prev 59.37%)
Tobins Q-Ratio = 1.13 (Enterprise Value 14.5b / Total Assets 12.8b)
Interest Expense / Debt = 8.16% (Interest Expense 24.0m / Debt 294.0m)
Taxrate = 28.21% (265.0m / 939.5m)
NOPAT = 637.2m (EBIT 887.5m * (1 - 28.21%))
Current Ratio = 1.90 (Total Current Assets 6.66b / Total Current Liabilities 3.51b)
Debt / Equity = 0.03 (Debt 294.0m / totalStockholderEquity, last quarter 8.60b)
Debt / EBITDA = -0.79 (Net Debt -906.0m / EBITDA 1.14b)
Debt / FCF = -2.33 (Net Debt -906.0m / FCF TTM 389.5m)
Total Stockholder Equity = 8.49b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.13% (Net Income 663.0m / Total Assets 12.8b)
RoE = 7.81% (Net Income TTM 663.0m / Total Stockholder Equity 8.49b)
RoCE = 10.31% (EBIT 887.5m / Capital Employed (Equity 8.49b + L.T.Debt 117.0m))
RoIC = 7.02% (NOPAT 637.2m / Invested Capital 9.07b)
WACC = 6.30% (E(15.4b)/V(15.7b) * Re(6.31%) + D(294.0m)/V(15.7b) * Rd(8.16%) * (1-Tc(0.28)))
Discount Rate = 6.31% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -81.65 | Cagr: -1.64%
[DCF] Terminal Value 73.10% ; FCFF base≈564.5m ; Y1≈495.0m ; Y5≈400.0m
[DCF] Fair Price = 33.52 (EV 6.42b - Net Debt -906.0m = Equity 7.33b / Shares 218.5m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 71.91 | EPS CAGR: 14.46% | SUE: -2.72 | # QB: -4
Revenue Correlation: 86.81 | Revenue CAGR: 2.12% | SUE: 0.00 | # QB: 0
EPS current Year (2026-12-31): EPS=4.30 | Chg30d=-0.14% | Revisions=-81% | GrowthEPS=-3.2% | GrowthRev=-0.2%
EPS next Year (2027-12-31): EPS=4.55 | Chg30d=-0.27% | Revisions=-82% | GrowthEPS=+5.8% | GrowthRev=+3.4%
[Analyst] Revisions Ratio: -82%